Israel’s ImmunArray is developing blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases, including brain injury. It has just received a major investment from America’s Quanterix Corporation.
Diagnoses using molecular biomarkers
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.